WVE Stock Analysis: Buy, Sell, or Hold?
WVE - Wave Life Sciences Ltd. Ordinary Shares
$6.62
0.25 (4.01%)
▲
5d:
-43.03%
30d:
-52.48%
90d:
-62.75%
WAIT
LOW Confidence
Analysis Updated: Mar 30, 2026 12:00 AM ET
Earnings: May 14, 2026
Smart Money Accumulation
WVE is down 45.1% this week, but smart money is accumulating calls. Top strike: $7 2026-05-15 with 1,283 OI. Call ratio: 100% View Scanner →
Strength: 10.0/10
Get Alerted When WVE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: WVE is down 43.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: WVE is down 43.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: WVE is currently trading at $6.62, which is considered oversold relative to its 30-day fair value range of $10.17 to $14.71.
Technical Outlook: Technically, WVE is in a uptrend. Immediate support is located at $5.02, while resistance sits at $12.67. The stock is showing strong short-term momentum, up 4.0% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $26.53 (+300.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, WVE is in a uptrend. Immediate support is located at $5.02, while resistance sits at $12.67. The stock is showing strong short-term momentum, up 4.0% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $26.53 (+300.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$10.17 -
$14.71
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
87.9%
Protect Your Profits
Holding WVE? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+4.0%)
- BULLISH: Trading 300.8% below Wall St target ($26.53)
- WARNING: Recommendation downgraded due to -43.0% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$10.17 -
$14.71
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$5.02
Resistance Level
$12.67
Current Trend
Uptrend
Technical data as of
Mar 30, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-5.22
Wall Street Target
$26.53
(+300.8%)
Revenue Growth (YoY)
-79.4%
Share & Embed Analysis
Last updated: March 30, 2026 6:36 PM ET
Data refreshes hourly during market hours. Next update: 7:36 PM
Data refreshes hourly during market hours. Next update: 7:36 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is WVE showing a specific setup today?
Insider Activity (6 Months)
1
Buys
15
Sells
Net
INSIDERS SELLING
Recent Transactions
Chris Francis
SELL
33194 shares
2026-02-26
Chandra Vargeese
SELL
3228 shares
2026-02-09
Chris Francis
SELL
1883 shares
2026-02-09
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$89 | 54 HOLD |
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$21 | 56 HOLD |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$58 | 51 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$84 | 50 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$547 | 44 HOLD |
Advanced WVE Option Strategies
Professional options setups generated by AI based on today's WVE price and gamma walls.
